BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38016407)

  • 1. Network connectivity and local transcriptomic vulnerability underpin cortical atrophy progression in Parkinson's disease.
    Vo A; Tremblay C; Rahayel S; Shafiei G; Hansen JY; Yau Y; Misic B; Dagher A
    Neuroimage Clin; 2023; 40():103523. PubMed ID: 38016407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional transcriptional architecture of Parkinson's disease pathogenesis and network spread.
    Freeze B; Pandya S; Zeighami Y; Raj A
    Brain; 2019 Oct; 142(10):3072-3085. PubMed ID: 31359041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain atrophy progression in Parkinson's disease is shaped by connectivity and local vulnerability.
    Tremblay C; Rahayel S; Vo A; Morys F; Shafiei G; Abbasi N; Markello RD; Gan-Or Z; Misic B; Dagher A
    Brain Commun; 2021; 3(4):fcab269. PubMed ID: 34859216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
    Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of Parkinson's disease patients' subtypes based on cortical thinning: 4-year follow-up.
    Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2019 Jul; 64():286-292. PubMed ID: 31103485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
    Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex effects on brain structure in de novo Parkinson's disease: a multimodal neuroimaging study.
    Tremblay C; Abbasi N; Zeighami Y; Yau Y; Dadar M; Rahayel S; Dagher A
    Brain; 2020 Oct; 143(10):3052-3066. PubMed ID: 32980872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in network controllability and regional gene expression underlie hallucinations in Parkinson's disease.
    Zarkali A; McColgan P; Ryten M; Reynolds R; Leyland LA; Lees AJ; Rees G; Weil RS
    Brain; 2020 Dec; 143(11):3435-3448. PubMed ID: 33118028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal Forebrain Atrophy, Cortical Thinning, and Amyloid-β Status in Parkinson's disease-Related Cognitive Decline.
    Labrador-Espinosa MA; Silva-Rodríguez J; Reina-Castillo MI; Mir P; Grothe MJ
    Mov Disord; 2023 Oct; 38(10):1871-1880. PubMed ID: 37492892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging.
    Zeighami Y; Fereshtehnejad SM; Dadar M; Collins DL; Postuma RB; Mišić B; Dagher A
    Neuroimage; 2019 Apr; 190():69-78. PubMed ID: 29277406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of integrity and atrophy in cingulate structural covariance networks in Parkinson's disease.
    de Schipper LJ; van der Grond J; Marinus J; Henselmans JML; van Hilten JJ
    Neuroimage Clin; 2017; 15():587-593. PubMed ID: 28652971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of cortical thinning in nondemented Parkinson's disease patients.
    Uribe C; Segura B; Baggio HC; Abos A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
    Mov Disord; 2016 May; 31(5):699-708. PubMed ID: 27094093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric similarity differences in drug-naive Parkinson's disease correlate with transcriptomic signatures.
    Wang Y; Xiao Y; Xing Y; Yu M; Wang X; Ren J; Liu W; Zhong Y
    CNS Neurosci Ther; 2024 Mar; 30(3):e14680. PubMed ID: 38529533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson's disease.
    Thomas GEC; Zarkali A; Ryten M; Shmueli K; Gil-Martinez AL; Leyland LA; McColgan P; Acosta-Cabronero J; Lees AJ; Weil RS
    Brain; 2021 Jul; 144(6):1787-1798. PubMed ID: 33704443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical thinning across Parkinson's disease stages and clinical correlates.
    Wilson H; Niccolini F; Pellicano C; Politis M
    J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia.
    Shafiei G; Bazinet V; Dadar M; Manera AL; Collins DL; Dagher A; Borroni B; Sanchez-Valle R; Moreno F; Laforce R; Graff C; Synofzik M; Galimberti D; Rowe JB; Masellis M; Tartaglia MC; Finger E; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Butler C; Gerhard A; Danek A; Levin J; Otto M; Sorbi S; Jiskoot LC; Seelaar H; van Swieten JC; Rohrer JD; Misic B; Ducharme S; ;
    Brain; 2023 Jan; 146(1):321-336. PubMed ID: 35188955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expression.
    Rahayel S; Tremblay C; Vo A; Zheng YQ; Lehéricy S; Arnulf I; Vidailhet M; Corvol JC; ; Gagnon JF; Postuma RB; Montplaisir J; Lewis S; Matar E; Ehgoetz Martens K; Borghammer P; Knudsen K; Hansen A; Monchi O; Misic B; Dagher A
    Brain; 2022 Sep; 145(9):3162-3178. PubMed ID: 35594873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
    Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
    Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis.
    Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Tolosa E; Junque C
    Parkinsonism Relat Disord; 2018 May; 50():3-9. PubMed ID: 29449187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Connectomics and Disease Progression in Drug-Naïve Parkinson's Disease Patients.
    De Micco R; Agosta F; Basaia S; Siciliano M; Cividini C; Tedeschi G; Filippi M; Tessitore A
    Mov Disord; 2021 Jul; 36(7):1603-1616. PubMed ID: 33639029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.